US Stock MarketDetailed Quotes
LCTX Lineage Cell Therapeutics
- 0.504
- -0.096-16.02%
Close Nov 22 16:00 ET
- 0.520
- +0.016+3.20%
Post 19:59 ET
115.05MMarket Cap-5039P/E (TTM)
0.620High0.500Low15.61MVolume0.620Open0.600Pre Close8.40MTurnover8.40%Turnover RatioLossP/E (Static)228.31MShares1.61052wk High1.74P/B93.63MFloat Cap0.50052wk Low--Dividend TTM185.81MShs Float78.000Historical High--Div YieldTTM20.02%Amplitude0.100Historical Low0.538Avg Price1Lot Size
Lineage Cell Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -20.86%32.71M | -16.18%38.5M | -6.82%43.62M | -38.67%35.49M | -38.67%35.49M | -37.71%41.33M | -36.24%45.93M | -41.44%46.81M | -0.83%57.88M | -0.83%57.88M |
| -Cash and cash equivalents | -11.83%27.75M | -12.58%29.62M | 182.03%43.58M | 212.13%35.44M | 212.13%35.44M | 27.16%31.47M | -52.18%33.89M | -80.21%15.45M | -79.63%11.36M | -79.63%11.36M |
| -Short-term investments | -49.68%4.96M | -26.29%8.87M | -99.86%45K | -99.89%50K | -99.89%50K | -76.30%9.86M | 926.34%12.04M | 1,566.47%31.36M | 1,678.29%46.52M | 1,678.29%46.52M |
| Receivables | -6.25%405K | -46.95%235K | -62.07%77K | 150.84%745K | 150.84%745K | -0.46%432K | -37.34%443K | -60.58%203K | -99.42%297K | -99.42%297K |
| -Accounts receivable | -6.25%405K | -46.95%235K | -62.07%77K | 150.84%745K | 150.84%745K | -0.46%432K | -37.34%443K | -60.58%203K | -99.42%297K | -99.42%297K |
| Other current assets | -25.16%1.29M | -21.86%1.66M | -23.50%2.02M | 20.57%2.2M | 20.57%2.2M | -0.17%1.72M | 64.70%2.12M | 86.69%2.64M | -22.25%1.83M | -22.25%1.83M |
| Total current assets | -20.88%34.4M | -16.71%40.39M | -7.93%45.72M | -35.93%38.44M | -35.93%38.44M | -36.53%43.48M | -34.49%48.49M | -39.35%49.66M | -46.21%60M | -46.21%60M |
| Non current assets | ||||||||||
| Net PPE | -9.87%4.38M | -13.33%4.6M | -11.19%4.96M | -15.97%4.77M | -15.97%4.77M | 4.34%4.85M | 37.24%5.31M | 22.78%5.58M | 16.44%5.67M | 16.44%5.67M |
| -Gross PPE | -25.16%8.57M | -26.13%8.64M | -23.64%8.93M | 4.18%12.01M | 4.18%12.01M | 9.40%11.45M | 24.21%11.69M | 15.38%11.69M | 13.26%11.52M | 13.26%11.52M |
| -Accumulated depreciation | 36.41%-4.19M | 36.77%-4.04M | 35.01%-3.97M | -23.73%-7.24M | -23.73%-7.24M | -13.45%-6.59M | -15.11%-6.38M | -9.36%-6.11M | -10.34%-5.85M | -10.34%-5.85M |
| Goodwill and other intangible assets | -0.09%57.21M | -0.15%57.21M | -0.21%57.21M | -0.23%57.23M | -0.23%57.23M | -0.23%57.27M | -0.23%57.3M | -0.23%57.33M | -0.23%57.36M | -0.23%57.36M |
| -Goodwill | 0.00%10.67M | 0.00%10.67M | 0.00%10.67M | 0.00%10.67M | 0.00%10.67M | 0.00%10.67M | 0.00%10.67M | 0.00%10.67M | 0.00%10.67M | 0.00%10.67M |
| -Other intangible assets | -0.12%46.54M | -0.19%46.54M | -0.26%46.54M | -0.28%46.56M | -0.28%46.56M | -0.28%46.59M | -0.28%46.63M | -0.28%46.66M | -0.28%46.69M | -0.28%46.69M |
| Other non current assets | 9.78%606K | 1.70%598K | -6.14%596K | -7.97%577K | -7.97%577K | -6.60%552K | -1.67%588K | -0.63%635K | -0.48%627K | -0.48%627K |
| Total non current assets | -0.76%62.19M | -1.24%62.41M | -1.23%62.77M | -1.71%62.58M | -1.71%62.58M | 0.05%62.67M | 2.10%63.2M | 1.44%63.55M | 1.06%63.66M | 1.06%63.66M |
| Total assets | -9.00%96.59M | -7.96%102.8M | -4.17%108.48M | -18.31%101.02M | -18.31%101.02M | -19.06%106.15M | -17.83%111.69M | -21.67%113.21M | -29.15%123.66M | -29.15%123.66M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -34.20%1.6M | 9.19%2.39M | -26.32%2.21M | -14.33%2.05M | -14.33%2.05M | -15.18%2.43M | -15.53%2.19M | 1.52%3M | -32.46%2.39M | -32.46%2.39M |
| -accounts payable | -34.20%1.6M | 9.19%2.39M | -26.32%2.21M | -14.33%2.05M | -14.33%2.05M | -15.18%2.43M | -15.53%2.19M | 1.52%3M | -32.46%2.39M | -32.46%2.39M |
| Current accrued expenses | 10.03%384K | -28.74%414K | 145.30%991K | -71.38%1.1M | -71.38%1.1M | -93.02%349K | -87.07%581K | -90.68%404K | -82.65%3.83M | -82.65%3.83M |
| Current debt and capital lease obligation | 21.47%1.14M | 12.97%1.12M | 14.33%1.1M | -7.35%882K | -7.35%882K | 64.79%936K | 58.68%987K | 28.40%963K | 14.56%952K | 14.56%952K |
| -Current capital lease obligation | 21.47%1.14M | 12.97%1.12M | 14.33%1.1M | -7.35%882K | -7.35%882K | 64.79%936K | 58.68%987K | 28.40%963K | 14.56%952K | 14.56%952K |
| Current deferred liabilities | -16.79%8.25M | -11.92%9.14M | -8.20%10.11M | 14.72%10.81M | 14.72%10.81M | -19.81%9.92M | -34.25%10.38M | -26.04%11.01M | -48.00%9.42M | -48.00%9.42M |
| Other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | -90.00%1K | -51.90%38K | ---- | ---- |
| Current liabilities | -12.70%13.86M | -4.84%15.28M | -1.94%16.89M | -5.38%17.96M | -5.38%17.96M | -30.16%15.88M | -36.02%16.05M | -29.96%17.23M | -59.71%18.98M | -59.71%18.98M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -24.77%1.61M | -24.04%1.84M | -19.51%2.15M | -29.69%2.07M | -29.69%2.07M | -3.94%2.14M | 63.53%2.42M | 48.04%2.68M | 49.37%2.94M | 49.37%2.94M |
| -Long term capital lease obligation | -24.77%1.61M | -24.04%1.84M | -19.51%2.15M | -29.69%2.07M | -29.69%2.07M | -3.94%2.14M | 63.53%2.42M | 48.04%2.68M | 49.37%2.94M | 49.37%2.94M |
| Non current deferred liabilities | -23.97%16.32M | -14.32%18.82M | -24.04%18.45M | -36.36%18.97M | -36.36%18.97M | -24.99%21.47M | -21.15%21.96M | -26.16%24.29M | -13.70%29.8M | -13.70%29.8M |
| Other non current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -93.33%2K | -93.33%2K |
| Total non current liabilities | -24.04%17.94M | -15.28%20.65M | -23.59%20.6M | -35.76%21.04M | -35.76%21.04M | -23.48%23.61M | -16.89%24.38M | -22.31%26.97M | -10.36%32.75M | -10.36%32.75M |
| Total liabilities | -19.48%31.8M | -11.14%35.93M | -15.16%37.49M | -24.61%39M | -24.61%39M | -26.31%39.49M | -25.71%40.43M | -25.48%44.19M | -38.16%51.73M | -38.16%51.73M |
| Shareholders'equity | ||||||||||
| Share capital | 4.22%469.27M | 4.39%467.93M | 5.73%466.57M | 2.51%451.34M | 2.51%451.34M | 2.54%450.28M | 2.54%448.25M | 1.26%441.3M | 1.32%440.28M | 1.32%440.28M |
| -common stock | 4.22%469.27M | 4.39%467.93M | 5.73%466.57M | 2.51%451.34M | 2.51%451.34M | 2.54%450.28M | 2.54%448.25M | 1.26%441.3M | 1.32%440.28M | 1.32%440.28M |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -5.29%-400.19M | -6.48%-397.16M | -6.43%-391.4M | -5.91%-384.86M | -5.91%-384.86M | -6.46%-380.08M | -6.28%-372.97M | -6.84%-367.74M | -7.79%-363.37M | -7.79%-363.37M |
| Gains losses not affecting retained earnings | -38.68%-2.89M | 5.40%-2.47M | 10.81%-2.77M | 14.09%-3.07M | 14.09%-3.07M | 34.55%-2.08M | 22.22%-2.61M | 38.92%-3.11M | 31.47%-3.57M | 31.47%-3.57M |
| Total stockholders'equity | -2.83%66.19M | -6.01%68.3M | 2.77%72.4M | -13.53%63.42M | -13.53%63.42M | -13.72%68.12M | -12.29%72.67M | -18.60%70.45M | -20.47%73.34M | -20.47%73.34M |
| Noncontrolling interests | 4.46%-1.39M | -1.14%-1.43M | 1.60%-1.41M | 0.50%-1.4M | 0.50%-1.4M | -4.44%-1.46M | -4.53%-1.41M | -7.98%-1.44M | -6.05%-1.4M | -6.05%-1.4M |
| Total equity | -2.80%64.79M | -6.15%66.88M | 2.86%70.99M | -13.78%62.02M | -13.78%62.02M | -14.05%66.66M | -12.57%71.26M | -19.01%69.02M | -20.86%71.94M | -20.86%71.94M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data